About Cambrian Bio
Cambrian Bio is a private company based in New York, New York. It has reported $148,416,656 raised in four offerings on Form D since January 2020. Its chief executive is James Peyer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 2023 | Dec 22, 2023amended Jan 13, 2025 | $23,022,065of $37.6M target | 30 | $767K | Options, Simple Agreement for Future EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 13, 2021 | Dec 2, 2021 | $92,209,653of $100.7M target | 56 | $1.6M | Equity, OptionsRule 506(b) | Form D ↗ |
| Oct 20, 2020 | May 6, 2021 | $28,434,938fully sold | 30 | $947K | Equity, Debt, OptionsRule 506(b) | Form D ↗ |
| Oct 29, 2019 | Jan 27, 2020 | $4,750,000fully sold | 5 | $950K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, four offerings | $148,416,656 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cambrian Bio's Form D filed Jan 13, 2025.
-modified.png)
-modified.png)
Earlier filings also listed William DeVaul (chief legal officer, last listed Jul 2026), Ruth Thieroff-Ekerdt (executive officer, last listed Jul 2026), Martin Gunhaga (director, last listed Jul 2026), Mark Nuttall (executive officer, last listed Jul 2026), Lorin Van Nuland (director, last listed Jul 2026), Juliette Han (executive officer and director, last listed Jul 2026) and Christian Angermeyer (director, last listed Jul 2026).